CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2015-12

AUTHORS

Franziska Niehr, Wilko Weichert, Albrecht Stenzinger, Volker Budach, Ingeborg Tinhofer

ABSTRACT

BACKGROUND: The mammalian target of rapamycin (mTOR) signaling pathway plays a pivotal role in numerous cellular processes involving growth, proliferation and survival. The purpose of this study was to investigate the anti-tumoral effect of the mTOR inhibitor (mTORi) CCI-779 in HNSCC cell lines and its potency in cisplatin- and cetuximab-resistant cells. METHODS: A panel of 10 HNSCC cell lines with differences in TP53 mutational status and basal cisplatin sensitivity and two isogenic models of acquired resistance to cisplatin and cetuximab, respectively were studied. Cell survival after treatment with CCI-779, cisplatin and cetuximab alone or in combination was determined by MTT assays. Potential predictive biomarkers for tumor cell sensitivity to CCI-779 were evaluated. RESULTS: We observed considerable heterogeneity in sensitivity of HNSCC cell lines to CCI-779 monotherapy. Sensitivity was observed in TP53 mutated as well as wild-type cell lines. Total and p-EGFR expression levels but not the basal activity of the mTOR and MAPK signaling pathways were correlated with sensitivity to CCI-779. Resistant cells with increased EGFR activation could be sensitized by the combination of CCI-779 with cetuximab. Interestingly, cell lines with acquired resistance to cisplatin displayed a higher sensitivity to CCI-779 whereas cetuximab-resistant cells were less sensitive to the drug, but could be sensitized to CCI-779 by EGFR blockade. CONCLUSIONS: Activity of CCI-779 in HNSCC cells harboring TP53 mutations and displaying a phenotype of cisplatin resistance suggests its clinical potential even in patients with dismal outcome after current standard treatment. Cetuximab/mTORi combinations might be useful for treatment of tumors with high expression of EGFR/p-EGFR and/or acquired cetuximab resistance. This combinatorial treatment modality needs further evaluation in future translational and clinical studies. More... »

PAGES

106

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12967-015-0456-6

DOI

http://dx.doi.org/10.1186/s12967-015-0456-6

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1009671977

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/25890004


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/0601", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biochemistry and Cell Biology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/06", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Biological Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Squamous Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Line, Tumor", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Proliferation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cell Survival", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cetuximab", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cisplatin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Resistance, Neoplasm", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "ErbB Receptors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Head and Neck Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Mutation", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Messenger", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Signal Transduction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Sirolimus", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Squamous Cell Carcinoma of Head and Neck", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "TOR Serine-Threonine Kinases", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Charit\u00e9", 
          "id": "https://www.grid.ac/institutes/grid.6363.0", 
          "name": [
            "Translational Radiooncology Laboratory, Department of Radiooncology and Radiotherapy, Charit\u00e9 University Hospital, Berlin, Germany", 
            "German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, Partner Site Berlin, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Niehr", 
        "givenName": "Franziska", 
        "id": "sg:person.01313445524.69", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313445524.69"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "German Cancer Research Center", 
          "id": "https://www.grid.ac/institutes/grid.7497.d", 
          "name": [
            "Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany", 
            "German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, Partner Site Heidelberg, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weichert", 
        "givenName": "Wilko", 
        "id": "sg:person.0657434205.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657434205.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University Hospital Heidelberg", 
          "id": "https://www.grid.ac/institutes/grid.5253.1", 
          "name": [
            "Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stenzinger", 
        "givenName": "Albrecht", 
        "id": "sg:person.0642700650.98", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642700650.98"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Charit\u00e9", 
          "id": "https://www.grid.ac/institutes/grid.6363.0", 
          "name": [
            "Translational Radiooncology Laboratory, Department of Radiooncology and Radiotherapy, Charit\u00e9 University Hospital, Berlin, Germany", 
            "German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, Partner Site Berlin, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Budach", 
        "givenName": "Volker", 
        "id": "sg:person.0614600715.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614600715.55"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Charit\u00e9", 
          "id": "https://www.grid.ac/institutes/grid.6363.0", 
          "name": [
            "Translational Radiooncology Laboratory, Department of Radiooncology and Radiotherapy, Charit\u00e9 University Hospital, Berlin, Germany", 
            "German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, Partner Site Berlin, Berlin, Germany", 
            "Department of Radiooncology and Radiotherapy, Translational Radiooncology Laboratory, Charit\u00e9-Universit\u00e4tsmedizin Berlin, Charit\u00e9platz 1, 10117, Berlin, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tinhofer", 
        "givenName": "Ingeborg", 
        "id": "sg:person.01137504062.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137504062.40"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1093/nar/gkg509", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002198958"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-11-388", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002486939", 
          "https://doi.org/10.1186/1471-2407-11-388"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-11-388", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002486939", 
          "https://doi.org/10.1186/1471-2407-11-388"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2014.241", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004483500", 
          "https://doi.org/10.1038/bjc.2014.241"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.2014.241", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004483500", 
          "https://doi.org/10.1038/bjc.2014.241"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1476-4598-10-19", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005218442", 
          "https://doi.org/10.1186/1476-4598-10-19"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/nar/gkq929", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005486377"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/sj.bjc.6603656", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006318896", 
          "https://doi.org/10.1038/sj.bjc.6603656"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-10-0905", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007640464"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-13-0157", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007814210"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-12-1371", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014184880"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-11-2824", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014513897"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jmoldx.2013.06.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015693520"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/0008-5472.can-10-2614", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019162879"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.oraloncology.2008.02.006", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020341762"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-12-2716", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022035398"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14728214.2013.842976", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023455295"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1073/pnas.0912493107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025732418"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s1470-2045(09)70311-0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028155532"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1593/neo.13432", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028264997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1593/neo.13432", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028264997"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/0284186x.2013.864050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028594798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/0284186x.2013.864050", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028594798"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.18632/oncotarget.2223", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028900472"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.oraloncology.2012.12.016", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030074579"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1593/neo.121212", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030620534"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1593/neo.121212", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030620534"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2010.12.019", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034888434"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-007-0609-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036565440", 
          "https://doi.org/10.1007/s00280-007-0609-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-007-0609-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036565440", 
          "https://doi.org/10.1007/s00280-007-0609-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1208130", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038068253"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1208130", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038068253"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2013.06.2043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039183428"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2013.06.2043", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039183428"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1535-7163.mct-08-1184", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039567578"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3390/ijms13021886", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040131820"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hed.23813", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040935458"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/2159-8290.cd-13-0103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041696305"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/2159-8290.cd-13-0103", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1041696305"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/nar/gkf493", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043756780"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci37539", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043989506"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3322/canjclin.55.2.74", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048020321"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbrc.2013.09.130", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050422330"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.bbrc.2013.09.130", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050422330"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hed.23046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051293140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/hed.23046", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1051293140"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2013.54.3660", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1052990683"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1206923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062464764"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1126/science.1206923", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062464764"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.05.2308", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064204262"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/or.2011.1146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071531259"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/or.2012.1801", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1071531858"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082391920", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2015-12", 
    "datePublishedReg": "2015-12-01", 
    "description": "BACKGROUND: The mammalian target of rapamycin (mTOR) signaling pathway plays a pivotal role in numerous cellular processes involving growth, proliferation and survival. The purpose of this study was to investigate the anti-tumoral effect of the mTOR inhibitor (mTORi) CCI-779 in HNSCC cell lines and its potency in cisplatin- and cetuximab-resistant cells.\nMETHODS: A panel of 10 HNSCC cell lines with differences in TP53 mutational status and basal cisplatin sensitivity and two isogenic models of acquired resistance to cisplatin and cetuximab, respectively were studied. Cell survival after treatment with CCI-779, cisplatin and cetuximab alone or in combination was determined by MTT assays. Potential predictive biomarkers for tumor cell sensitivity to CCI-779 were evaluated.\nRESULTS: We observed considerable heterogeneity in sensitivity of HNSCC cell lines to CCI-779 monotherapy. Sensitivity was observed in TP53 mutated as well as wild-type cell lines. Total and p-EGFR expression levels but not the basal activity of the mTOR and MAPK signaling pathways were correlated with sensitivity to CCI-779. Resistant cells with increased EGFR activation could be sensitized by the combination of CCI-779 with cetuximab. Interestingly, cell lines with acquired resistance to cisplatin displayed a higher sensitivity to CCI-779 whereas cetuximab-resistant cells were less sensitive to the drug, but could be sensitized to CCI-779 by EGFR blockade.\nCONCLUSIONS: Activity of CCI-779 in HNSCC cells harboring TP53 mutations and displaying a phenotype of cisplatin resistance suggests its clinical potential even in patients with dismal outcome after current standard treatment. Cetuximab/mTORi combinations might be useful for treatment of tumors with high expression of EGFR/p-EGFR and/or acquired cetuximab resistance. This combinatorial treatment modality needs further evaluation in future translational and clinical studies.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12967-015-0456-6", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1032886", 
        "issn": [
          "1479-5876"
        ], 
        "name": "Journal of Translational Medicine", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "13"
      }
    ], 
    "name": "CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab", 
    "pagination": "106", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "2e135fcfd5fe7fac8f5862c832ddbc0daf69bf39368327da6251bdf796825c2b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "25890004"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101190741"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12967-015-0456-6"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1009671977"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12967-015-0456-6", 
      "https://app.dimensions.ai/details/publication/pub.1009671977"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T13:10", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000367_0000000367/records_88247_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2Fs12967-015-0456-6"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12967-015-0456-6'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12967-015-0456-6'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12967-015-0456-6'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12967-015-0456-6'


 

This table displays all metadata directly associated to this object as RDF triples.

300 TRIPLES      21 PREDICATES      87 URIs      38 LITERALS      26 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12967-015-0456-6 schema:about N03bb2563905f42c8862cd9d22e332d62
2 N08e36399dd2a474493f21c745915088b
3 N17882e7b39e048bebed430c8094cd612
4 N2c250c208ba849b1bfe901931af6687e
5 N45d2f2e48c854e54ba0677ac64b106b7
6 N51d87f367522472997fbd96c8359eca7
7 N716472cd184e4d199c231f29464a60ea
8 N80c0fc812d2a4229946591e94fe1cd30
9 N824beea6b1ae4d488edf69ec0e329452
10 Na2ad130e2bb348bdb11bfbc6dc2e1cc8
11 Nacc165bb204649b5904c5adf77cc828f
12 Nb3ce2ae8663b49d299fa4cfd78fb0e0f
13 Nb434f6d4902646a89d4728313947332e
14 Nc0c26545fdf34046beafcf16a7b07912
15 Nd2849add2bd24c85838b3ec471ddafcd
16 Ndf4ebf6106654a0880c6a26921826108
17 Neb73644beb694525a3bfa763ef8e4915
18 anzsrc-for:06
19 anzsrc-for:0601
20 schema:author Nbd8e959b02884945964e9429bb914299
21 schema:citation sg:pub.10.1007/s00280-007-0609-2
22 sg:pub.10.1038/bjc.2014.241
23 sg:pub.10.1038/sj.bjc.6603656
24 sg:pub.10.1186/1471-2407-11-388
25 sg:pub.10.1186/1476-4598-10-19
26 https://app.dimensions.ai/details/publication/pub.1082391920
27 https://doi.org/10.1002/hed.23046
28 https://doi.org/10.1002/hed.23813
29 https://doi.org/10.1016/j.bbrc.2013.09.130
30 https://doi.org/10.1016/j.ejca.2010.12.019
31 https://doi.org/10.1016/j.ijrobp.2013.06.2043
32 https://doi.org/10.1016/j.jmoldx.2013.06.002
33 https://doi.org/10.1016/j.oraloncology.2008.02.006
34 https://doi.org/10.1016/j.oraloncology.2012.12.016
35 https://doi.org/10.1016/s1470-2045(09)70311-0
36 https://doi.org/10.1073/pnas.0912493107
37 https://doi.org/10.1093/nar/gkf493
38 https://doi.org/10.1093/nar/gkg509
39 https://doi.org/10.1093/nar/gkq929
40 https://doi.org/10.1126/science.1206923
41 https://doi.org/10.1126/science.1208130
42 https://doi.org/10.1158/0008-5472.can-10-2614
43 https://doi.org/10.1158/1078-0432.ccr-11-2824
44 https://doi.org/10.1158/1078-0432.ccr-12-1371
45 https://doi.org/10.1158/1078-0432.ccr-12-2716
46 https://doi.org/10.1158/1535-7163.mct-08-1184
47 https://doi.org/10.1158/1535-7163.mct-10-0905
48 https://doi.org/10.1158/1535-7163.mct-13-0157
49 https://doi.org/10.1158/2159-8290.cd-13-0103
50 https://doi.org/10.1172/jci37539
51 https://doi.org/10.1200/jco.2005.05.2308
52 https://doi.org/10.1200/jco.2013.54.3660
53 https://doi.org/10.1517/14728214.2013.842976
54 https://doi.org/10.1593/neo.121212
55 https://doi.org/10.1593/neo.13432
56 https://doi.org/10.18632/oncotarget.2223
57 https://doi.org/10.3109/0284186x.2013.864050
58 https://doi.org/10.3322/canjclin.55.2.74
59 https://doi.org/10.3390/ijms13021886
60 https://doi.org/10.3892/or.2011.1146
61 https://doi.org/10.3892/or.2012.1801
62 schema:datePublished 2015-12
63 schema:datePublishedReg 2015-12-01
64 schema:description BACKGROUND: The mammalian target of rapamycin (mTOR) signaling pathway plays a pivotal role in numerous cellular processes involving growth, proliferation and survival. The purpose of this study was to investigate the anti-tumoral effect of the mTOR inhibitor (mTORi) CCI-779 in HNSCC cell lines and its potency in cisplatin- and cetuximab-resistant cells. METHODS: A panel of 10 HNSCC cell lines with differences in TP53 mutational status and basal cisplatin sensitivity and two isogenic models of acquired resistance to cisplatin and cetuximab, respectively were studied. Cell survival after treatment with CCI-779, cisplatin and cetuximab alone or in combination was determined by MTT assays. Potential predictive biomarkers for tumor cell sensitivity to CCI-779 were evaluated. RESULTS: We observed considerable heterogeneity in sensitivity of HNSCC cell lines to CCI-779 monotherapy. Sensitivity was observed in TP53 mutated as well as wild-type cell lines. Total and p-EGFR expression levels but not the basal activity of the mTOR and MAPK signaling pathways were correlated with sensitivity to CCI-779. Resistant cells with increased EGFR activation could be sensitized by the combination of CCI-779 with cetuximab. Interestingly, cell lines with acquired resistance to cisplatin displayed a higher sensitivity to CCI-779 whereas cetuximab-resistant cells were less sensitive to the drug, but could be sensitized to CCI-779 by EGFR blockade. CONCLUSIONS: Activity of CCI-779 in HNSCC cells harboring TP53 mutations and displaying a phenotype of cisplatin resistance suggests its clinical potential even in patients with dismal outcome after current standard treatment. Cetuximab/mTORi combinations might be useful for treatment of tumors with high expression of EGFR/p-EGFR and/or acquired cetuximab resistance. This combinatorial treatment modality needs further evaluation in future translational and clinical studies.
65 schema:genre research_article
66 schema:inLanguage en
67 schema:isAccessibleForFree true
68 schema:isPartOf N843e2f60f7fa4122a0a8af0217a6a4af
69 Ne93912eb63f14dcf9167a1dffb6cfa5e
70 sg:journal.1032886
71 schema:name CCI-779 (Temsirolimus) exhibits increased anti-tumor activity in low EGFR expressing HNSCC cell lines and is effective in cells with acquired resistance to cisplatin or cetuximab
72 schema:pagination 106
73 schema:productId N4f36e057eefd444ea72c32e142eafeb0
74 N9195a582418c4cdc9702272acab3304e
75 Nc5965b9ee12341cfa7fc606fae0dfd1b
76 Nd840b6fb4ff64026817dd8d296fcff05
77 Nf8efe00687ce4b82bd99785d1e87698e
78 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009671977
79 https://doi.org/10.1186/s12967-015-0456-6
80 schema:sdDatePublished 2019-04-11T13:10
81 schema:sdLicense https://scigraph.springernature.com/explorer/license/
82 schema:sdPublisher N9d9ec767b93b41f5b40300d4d7c5f8a5
83 schema:url http://link.springer.com/10.1186%2Fs12967-015-0456-6
84 sgo:license sg:explorer/license/
85 sgo:sdDataset articles
86 rdf:type schema:ScholarlyArticle
87 N03bb2563905f42c8862cd9d22e332d62 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name RNA, Messenger
89 rdf:type schema:DefinedTerm
90 N08e36399dd2a474493f21c745915088b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
91 schema:name Antineoplastic Agents
92 rdf:type schema:DefinedTerm
93 N17882e7b39e048bebed430c8094cd612 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Humans
95 rdf:type schema:DefinedTerm
96 N2c250c208ba849b1bfe901931af6687e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name TOR Serine-Threonine Kinases
98 rdf:type schema:DefinedTerm
99 N45d2f2e48c854e54ba0677ac64b106b7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Cisplatin
101 rdf:type schema:DefinedTerm
102 N4f36e057eefd444ea72c32e142eafeb0 schema:name readcube_id
103 schema:value 2e135fcfd5fe7fac8f5862c832ddbc0daf69bf39368327da6251bdf796825c2b
104 rdf:type schema:PropertyValue
105 N51d87f367522472997fbd96c8359eca7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
106 schema:name Carcinoma, Squamous Cell
107 rdf:type schema:DefinedTerm
108 N6a2f977217f9402fbb6a9913e945702f rdf:first sg:person.01137504062.40
109 rdf:rest rdf:nil
110 N716472cd184e4d199c231f29464a60ea schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Cell Survival
112 rdf:type schema:DefinedTerm
113 N80c0fc812d2a4229946591e94fe1cd30 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
114 schema:name Squamous Cell Carcinoma of Head and Neck
115 rdf:type schema:DefinedTerm
116 N824beea6b1ae4d488edf69ec0e329452 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
117 schema:name Drug Resistance, Neoplasm
118 rdf:type schema:DefinedTerm
119 N843e2f60f7fa4122a0a8af0217a6a4af schema:issueNumber 1
120 rdf:type schema:PublicationIssue
121 N9195a582418c4cdc9702272acab3304e schema:name dimensions_id
122 schema:value pub.1009671977
123 rdf:type schema:PropertyValue
124 N9ba5527ddec24e968d52e03f40f657e5 rdf:first sg:person.0642700650.98
125 rdf:rest Nee7571e87b984009b4e4bc4c3aeadb15
126 N9d9ec767b93b41f5b40300d4d7c5f8a5 schema:name Springer Nature - SN SciGraph project
127 rdf:type schema:Organization
128 Na2ad130e2bb348bdb11bfbc6dc2e1cc8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Signal Transduction
130 rdf:type schema:DefinedTerm
131 Na56ccd34e91c488d8e5618a39ed67dba rdf:first sg:person.0657434205.21
132 rdf:rest N9ba5527ddec24e968d52e03f40f657e5
133 Nacc165bb204649b5904c5adf77cc828f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name ErbB Receptors
135 rdf:type schema:DefinedTerm
136 Nb3ce2ae8663b49d299fa4cfd78fb0e0f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Mutation
138 rdf:type schema:DefinedTerm
139 Nb434f6d4902646a89d4728313947332e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Cell Proliferation
141 rdf:type schema:DefinedTerm
142 Nbd8e959b02884945964e9429bb914299 rdf:first sg:person.01313445524.69
143 rdf:rest Na56ccd34e91c488d8e5618a39ed67dba
144 Nc0c26545fdf34046beafcf16a7b07912 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Cell Line, Tumor
146 rdf:type schema:DefinedTerm
147 Nc5965b9ee12341cfa7fc606fae0dfd1b schema:name pubmed_id
148 schema:value 25890004
149 rdf:type schema:PropertyValue
150 Nd2849add2bd24c85838b3ec471ddafcd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Cetuximab
152 rdf:type schema:DefinedTerm
153 Nd840b6fb4ff64026817dd8d296fcff05 schema:name doi
154 schema:value 10.1186/s12967-015-0456-6
155 rdf:type schema:PropertyValue
156 Ndf4ebf6106654a0880c6a26921826108 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Sirolimus
158 rdf:type schema:DefinedTerm
159 Ne93912eb63f14dcf9167a1dffb6cfa5e schema:volumeNumber 13
160 rdf:type schema:PublicationVolume
161 Neb73644beb694525a3bfa763ef8e4915 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
162 schema:name Head and Neck Neoplasms
163 rdf:type schema:DefinedTerm
164 Nee7571e87b984009b4e4bc4c3aeadb15 rdf:first sg:person.0614600715.55
165 rdf:rest N6a2f977217f9402fbb6a9913e945702f
166 Nf8efe00687ce4b82bd99785d1e87698e schema:name nlm_unique_id
167 schema:value 101190741
168 rdf:type schema:PropertyValue
169 anzsrc-for:06 schema:inDefinedTermSet anzsrc-for:
170 schema:name Biological Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:0601 schema:inDefinedTermSet anzsrc-for:
173 schema:name Biochemistry and Cell Biology
174 rdf:type schema:DefinedTerm
175 sg:journal.1032886 schema:issn 1479-5876
176 schema:name Journal of Translational Medicine
177 rdf:type schema:Periodical
178 sg:person.01137504062.40 schema:affiliation https://www.grid.ac/institutes/grid.6363.0
179 schema:familyName Tinhofer
180 schema:givenName Ingeborg
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01137504062.40
182 rdf:type schema:Person
183 sg:person.01313445524.69 schema:affiliation https://www.grid.ac/institutes/grid.6363.0
184 schema:familyName Niehr
185 schema:givenName Franziska
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01313445524.69
187 rdf:type schema:Person
188 sg:person.0614600715.55 schema:affiliation https://www.grid.ac/institutes/grid.6363.0
189 schema:familyName Budach
190 schema:givenName Volker
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0614600715.55
192 rdf:type schema:Person
193 sg:person.0642700650.98 schema:affiliation https://www.grid.ac/institutes/grid.5253.1
194 schema:familyName Stenzinger
195 schema:givenName Albrecht
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0642700650.98
197 rdf:type schema:Person
198 sg:person.0657434205.21 schema:affiliation https://www.grid.ac/institutes/grid.7497.d
199 schema:familyName Weichert
200 schema:givenName Wilko
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657434205.21
202 rdf:type schema:Person
203 sg:pub.10.1007/s00280-007-0609-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036565440
204 https://doi.org/10.1007/s00280-007-0609-2
205 rdf:type schema:CreativeWork
206 sg:pub.10.1038/bjc.2014.241 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004483500
207 https://doi.org/10.1038/bjc.2014.241
208 rdf:type schema:CreativeWork
209 sg:pub.10.1038/sj.bjc.6603656 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006318896
210 https://doi.org/10.1038/sj.bjc.6603656
211 rdf:type schema:CreativeWork
212 sg:pub.10.1186/1471-2407-11-388 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002486939
213 https://doi.org/10.1186/1471-2407-11-388
214 rdf:type schema:CreativeWork
215 sg:pub.10.1186/1476-4598-10-19 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005218442
216 https://doi.org/10.1186/1476-4598-10-19
217 rdf:type schema:CreativeWork
218 https://app.dimensions.ai/details/publication/pub.1082391920 schema:CreativeWork
219 https://doi.org/10.1002/hed.23046 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051293140
220 rdf:type schema:CreativeWork
221 https://doi.org/10.1002/hed.23813 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040935458
222 rdf:type schema:CreativeWork
223 https://doi.org/10.1016/j.bbrc.2013.09.130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050422330
224 rdf:type schema:CreativeWork
225 https://doi.org/10.1016/j.ejca.2010.12.019 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034888434
226 rdf:type schema:CreativeWork
227 https://doi.org/10.1016/j.ijrobp.2013.06.2043 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039183428
228 rdf:type schema:CreativeWork
229 https://doi.org/10.1016/j.jmoldx.2013.06.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015693520
230 rdf:type schema:CreativeWork
231 https://doi.org/10.1016/j.oraloncology.2008.02.006 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020341762
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1016/j.oraloncology.2012.12.016 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030074579
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/s1470-2045(09)70311-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028155532
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1073/pnas.0912493107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025732418
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1093/nar/gkf493 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043756780
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1093/nar/gkg509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002198958
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1093/nar/gkq929 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005486377
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1126/science.1206923 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062464764
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1126/science.1208130 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038068253
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1158/0008-5472.can-10-2614 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019162879
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1158/1078-0432.ccr-11-2824 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014513897
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1158/1078-0432.ccr-12-1371 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014184880
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1158/1078-0432.ccr-12-2716 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022035398
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1158/1535-7163.mct-08-1184 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039567578
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1158/1535-7163.mct-10-0905 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007640464
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1158/1535-7163.mct-13-0157 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007814210
262 rdf:type schema:CreativeWork
263 https://doi.org/10.1158/2159-8290.cd-13-0103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1041696305
264 rdf:type schema:CreativeWork
265 https://doi.org/10.1172/jci37539 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043989506
266 rdf:type schema:CreativeWork
267 https://doi.org/10.1200/jco.2005.05.2308 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064204262
268 rdf:type schema:CreativeWork
269 https://doi.org/10.1200/jco.2013.54.3660 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052990683
270 rdf:type schema:CreativeWork
271 https://doi.org/10.1517/14728214.2013.842976 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023455295
272 rdf:type schema:CreativeWork
273 https://doi.org/10.1593/neo.121212 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030620534
274 rdf:type schema:CreativeWork
275 https://doi.org/10.1593/neo.13432 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028264997
276 rdf:type schema:CreativeWork
277 https://doi.org/10.18632/oncotarget.2223 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028900472
278 rdf:type schema:CreativeWork
279 https://doi.org/10.3109/0284186x.2013.864050 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028594798
280 rdf:type schema:CreativeWork
281 https://doi.org/10.3322/canjclin.55.2.74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048020321
282 rdf:type schema:CreativeWork
283 https://doi.org/10.3390/ijms13021886 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040131820
284 rdf:type schema:CreativeWork
285 https://doi.org/10.3892/or.2011.1146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071531259
286 rdf:type schema:CreativeWork
287 https://doi.org/10.3892/or.2012.1801 schema:sameAs https://app.dimensions.ai/details/publication/pub.1071531858
288 rdf:type schema:CreativeWork
289 https://www.grid.ac/institutes/grid.5253.1 schema:alternateName University Hospital Heidelberg
290 schema:name Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
291 rdf:type schema:Organization
292 https://www.grid.ac/institutes/grid.6363.0 schema:alternateName Charité
293 schema:name Department of Radiooncology and Radiotherapy, Translational Radiooncology Laboratory, Charité-Universitätsmedizin Berlin, Charitéplatz 1, 10117, Berlin, Germany
294 German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, Partner Site Berlin, Berlin, Germany
295 Translational Radiooncology Laboratory, Department of Radiooncology and Radiotherapy, Charité University Hospital, Berlin, Germany
296 rdf:type schema:Organization
297 https://www.grid.ac/institutes/grid.7497.d schema:alternateName German Cancer Research Center
298 schema:name German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ) Heidelberg, Partner Site Heidelberg, Heidelberg, Germany
299 Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany
300 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...